When marketing an edgy medical treatment, the last thing a company needs is a director being sued by federal health authorities.
Shareholders in Vitura Health – the ASX’s only profitable cannabis company – caught a lucky break last week when a majority failed to support the election of ex-chief medical officer Dr Ben Jansen to the Vitura board.
Loading...
Myriam Robin is a senior writer based in the Melbourne newsroom. She has previously been a Rear Window columnist and editor, and before that reported on financial markets and media. Connect with Myriam on Twitter. Email Myriam at myriam.robin@afr.com
